Given that Nrf2 is the main switch of the expression of the majority of antioxidant enzymes and PGC1α (mitochondria enhancer), activating Nrf2 appears to be a good therapeutic strategy to control oxidative stress in AD brains. Here, NFE2L2 is linked to Alzheimer disease.